ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07735
0,00%
Bitcoin
62.648,30
-0,38%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Twist Bioscience Corporation (TWST)

  7. Twist Bioscience Corporation (TWST) News

TWST Twist Bioscience Corporation

41,33
9,32 (29,12%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Twist Bioscience Corporation TWST NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
9,32 29,12% 41,33 01:44:08
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
38,28 35,1752 41,77 41,21 32,01
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:05BWTwist Bioscience Reports Fiscal Second Quarter 2024..
18.4.202414:00BWTwist Bioscience to Report Fiscal 2024 Second Quarter..
28.3.202413:00BWTwist Bioscience Launches Pangenome Spike-in Exome Panel to..
08.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202421:32EDGAR2Form 144 - Report of proposed sale of securities
06.3.202421:26EDGAR2Form 144 - Report of proposed sale of securities
06.3.202421:20EDGAR2Form 144 - Report of proposed sale of securities
06.3.202421:18EDGAR2Form 144 - Report of proposed sale of securities
06.3.202421:17EDGAR2Form 144 - Report of proposed sale of securities
05.3.202414:00BWTwist Bioscience Launches IVDR-compliant Precision Dx..
22.2.202414:00BWTwist Bioscience to Present at Upcoming Investor Conferences
12.2.202423:42EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:14EDGAR2Form 144 - Report of proposed sale of securities
07.2.202422:05EDGAR2Form 8-K - Current report
07.2.202414:00BWTwist Bioscience Corporation Announces Inducement Grants..
06.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202414:05BWTwist Bioscience and Element Biosciences Collaborate on..
06.2.202414:00BWTwist Bioscience Launches cfDNA Library Preparation Kit for..
05.2.202414:00BWTwist Bioscience Unveils Differentiated Ultra..
02.2.202422:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.2.202413:32EDGAR2Form 8-K - Current report
02.2.202413:30BWTwist Bioscience Reports Fiscal First Quarter 2024 Financial..
29.1.202422:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202414:00BWTwist Bioscience Expands Express Genes Rapid Synthesis..
16.1.202414:00BWTwist Bioscience to Report Fiscal 2024 First Quarter..
10.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.1.202414:00BWTwist Bioscience Corporation Announces Inducement Grant..
05.1.202422:07EDGAR2Form ARS - Annual Report to Security Holders
05.1.202422:02EDGAR2Form DEF 14A - Other definitive proxy statements
05.1.202414:08EDGAR2Form 8-K - Current report
05.1.202414:00BWTwist Bioscience Appoints Adam Laponis as Chief Financial..
04.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
TWST
Twist Bioscience
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten